The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Methods For Purifying Antibodies - EP2969098

The patent EP2969098 was granted to Glaxosmithkline on Oct 30, 2019. The application was originally filed on Mar 13, 2014 under application number EP14713926A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2969098

GLAXOSMITHKLINE
Application Number
EP14713926A
Filing Date
Mar 13, 2014
Status
Granted And Under Opposition
Sep 27, 2019
Publication Date
Oct 30, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WALLINGER RICKER SCHLOTTER TOSTMANNJul 30, 2020OETKE -

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0054951
DESCRIPTIONEP0239400
DESCRIPTIONUS2005043519
DESCRIPTIONWO0029004
INTERNATIONAL-SEARCH-REPORTWO2005082937
INTERNATIONAL-SEARCH-REPORTWO2007109163
OPPOSITIONWO2007109163
OPPOSITIONWO2014141150
OPPOSITIONWO2014186350

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents